1. Natural and chimeric chronokines for age-associated disorders
  2. AAV gene therapy strategies for rare diseases affecting the CNS:
    • Spastic Paraplegia type 52 (SPG52)
    • GNB1 Encephalopathy
    • ADSL Deficiency
  3. Design, generation and production of AAV and adenovirus vectors